Benefit from a clinical trial assay with multiple biomarkers for hereditary diseases
A precision medicine concept is pivotal for the success of clinical trials in Parkinson’s disease, Alzheimer´s disease, cardiomyopathies, fibrosis and other hereditary diseases.
By partnering with us, you have access to a single clinical trial exome assay developed by Helix – based on the Helix Laboratory Platform technology – with multiple biomarkers for your clinical drug development.
Why should you use this assay?
Covers 22,000 clinically relevant genes
DNA of more than 500,000 individuals sequenced
Enrollment and DNA sequencing of more than 100,000 patients a year
Capitalize on our global partnership with Helix and simplify identification of potential participants for your hereditary diseases clinical trials.
Call us during our office hours (Monday to Friday): 800-426-8157
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user operator manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).
This advertisement was sent by QIAGEN. If this email was forwarded to you and you‘d like to receive future communications and advertisements, please sign up here.
